Companies Cryptocurrencies
Vaccinex Inc
Vaccinex Inc
Exchange: NasdaqCM
IPO Date: 09/08/2018
CEO: Dr. Maurice Zauderer
Biotechnology Healthcare đź”—
  • VCNX
    symbol
  • 1.92
    price
  • 59138112
    market cap
  • 0
    changes
If you bought

shares of Vaccinex Inc (VCNX) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company is headquartered in Rochester, New York and currently employs 44 full-time employees. The firm is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The company provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. The company also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.

Address: 1895 Mount Hope Ave Rochester NEW YORK 14620

Stay updated.